PDL BioPharma, Inc. Enterprise Value

Enterprise Value of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Enterprise Value growth rates and interactive chart. Calculated as market cap + net debt. A company with a market cap of $1 billion and net cash of $500 million will have an enterprise value of $500 million. Not applicable to financial companies, due to the structure of cash on their balance sheet.


Highlights and Quick Summary

Current Enterprise Value of PDL BioPharma, Inc. is $243 Million (as of December 30, 2019)
  • Enterprise Value for the quarter ending June 29, 2020 was $220 Million (a 42.95% increase compared to previous quarter)
  • Year-over-year quarterly Enterprise Value increased by 167.72%
  • Annual Enterprise Value for 2019 was $243 Million (a 59.5% increase from previous year)
  • Annual Enterprise Value for 2018 was $152 Million (a 387.49% increase from previous year)
  • Annual Enterprise Value for 2017 was $31.3 Million (a -91.2% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Enterprise Value of PDL BioPharma, Inc.

Most recent Enterprise Valueof PDLI including historical data for past 10 years.

Interactive Chart of Enterprise Value of PDL BioPharma, Inc.

PDL BioPharma, Inc. Enterprise Value for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $220.24 $154.07
2019 $243.23 $82.26 $206.71 $240.66 $243.23
2018 $152.49 $86.88 $79.38 $154.87 $152.49
2017 $31.28 $113.12 $63.19 $74.81 $31.28
2016 $355.59 $594.24 $525.36 $484.02 $355.59
2015 $586.9 $874.61 $1,037.25 $1,004.56 $586.9
2014 $1,202.45 $1,187.26 $1,606.33 $1,189.81 $1,202.45
2013 $1,227.74 $935.15 $957.58 $1,131.65 $1,227.74
2012 $1,124.83 $1,225.13 $1,015.12 $1,018.59 $1,124.83
2011 $967.49 $895.61 $954.05 $892.93 $967.49
2010 $937.8 $783.96 $836.19 $937.8

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.